Structure-based engineering of benzalacetone synthase

被引:9
|
作者
Shimokawa, Yoshihiko [1 ]
Morita, Hiroyuki [1 ]
Abe, Ikuro [1 ]
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan
关键词
Polyketide synthase; Benzalacetone synthase; Enzyme; Site-directed mutagenesis; Enzyme engineering; III POLYKETIDE SYNTHASES; CHALCONE SYNTHASE; RHEUM-PALMATUM; CRYSTAL-STRUCTURE; BIOSYNTHESIS; SPECIFICITY; MECHANISM; COENZYME;
D O I
10.1016/j.bmcl.2010.07.022
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Benzalacetone synthase (BAS) and chalcone synthase (CHS) are plant-specific type III polyketide synthases (PKSs), sharing 70% amino acid sequence identity and highly homologous overall protein structures. BAS catalyzes the decarboxylative coupling of 4-coumaroyl-CoA with malonyl-CoA to produce the diketide benzalacetone, whereas CHS produces the tetraketide chalcone by iterative condensations with three molecules of malonyl-CoA, and folding the resulting intermediate into a new aromatic ring system. Recent crystallographic analyses of Rheum palmatum BAS revealed that the characteristic substitution of Thr132 (numbering of Medicago sativa CHS2), a conserved CHS residue lining the active-site cavity, with Leu causes steric contraction of the BAS active-site to produce the diketide, instead of the tetraketide. To test this hypothesis, we constructed a set of R. palmatum BAS site-directed mutants (L132G, L132A, L132S, L132C, L132T, L132F, L132Y, L132W and L132P), and investigated the mechanistic consequences of the point mutations. As a result, the single amino acid substitution L132T restored the chalcone-forming activity in BAS, whereas the Ala, Ser, and Cys substitutions expanded the product chain length to produce 4-coumaroyltriacetic acid lactone (CTAL) after three condensations with malonyl-CoA, but without the formation of the aromatic ring system. Homology modeling suggested that this is probably caused by the restoration of the 'coumaroyl binding pocket' in the active-site cavity. These findings provide further insights into the structural details of the catalytic mechanism of the type III PKS enzymes. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5099 / 5103
页数:5
相关论文
共 50 条
  • [21] Structure-Based Engineering of Angucyclinone 6-Ketoreductases
    Patrikainen, Pekka
    Niiranen, Laila
    Thapa, Keshav
    Paananen, Pasi
    Tahtinen, Petri
    Mantsala, Pekka
    Niemi, Jarmo
    Metsa-Ketela, Mikko
    CHEMISTRY & BIOLOGY, 2014, 21 (10): : 1381 - 1391
  • [22] Structure-based engineering of an infrared fluorescent protein marker
    Puetz, Stephanie Lynn
    Meraz, Jacqueline
    Varela, Angela
    Igova, Brigitte
    Baker, Anna
    Schirmer, Aaron E.
    Stojkovic, Emina A.
    Kennis, John T. M.
    FASEB JOURNAL, 2013, 27
  • [23] Structure-Based Engineering of an Icosahedral Virus for Nanomedicine and Nanotechnology
    Steinmetz, N. F.
    Lin, T.
    Lomonossoff, G. P.
    Johnson, J. E.
    VIRUSES AND NANOTECHNOLOGY, 2009, 327 : 23 - 58
  • [24] Structure-based Analysis of Dynamic Engineering Process Behavior
    Kasperek, Daniel
    Maisenbacher, Sebastian
    Maurer, Maik
    2014 8TH ANNUAL IEEE SYSTEMS CONFERENCE (SYSCON), 2014, : 83 - 88
  • [25] Structure-based engineering of designed armadillo repeat proteins
    Hansen, S.
    Reichen, C.
    Madhurantakam, C.
    Grutter, M.
    Pluckthun, A.
    Mittl, P.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2014, 70 : C1153 - C1153
  • [26] Structure-based inhibitor design of human hematopoietic prostaglandin D synthase
    Inoue, T
    Kai, Y
    Urade, Y
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2005, 63 (07) : 739 - 745
  • [27] Structure-based studies on species-specific inhibition of thymidylate synthase
    Costi, MP
    Tondi, D
    Rinaldi, M
    Barlocco, D
    Pecorari, P
    Soragni, F
    Venturelli, A
    Stroud, RM
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (2-3): : 206 - 214
  • [28] Structure-based design and combinatorial optimization of novel thymidylate synthase inhibitors
    Tondi, D
    Slomczynska, U
    Ghelli, S
    Watterson, DN
    Costi, MP
    Shoichet, BK
    FASEB JOURNAL, 1997, 11 (09): : A837 - A837
  • [29] ATP synthase FOF1 structure, function, and structure-based drug design
    Vlasov, Alexey V.
    Osipov, Stepan D.
    Bondarev, Nikolay A.
    Uversky, Vladimir N.
    Borshchevskiy, Valentin, I
    Yanyushin, Mikhail F.
    Manukhov, Ilya, V
    Rogachev, Andrey, V
    Vlasova, Anastasiia D.
    Ilyinsky, Nikolay S.
    Kuklin, Alexandr, I
    Dencher, Norbert A.
    Gordeliy, Valentin, I
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (03)
  • [30] ATP synthase FOF1 structure, function, and structure-based drug design
    Alexey V. Vlasov
    Stepan D. Osipov
    Nikolay A. Bondarev
    Vladimir N. Uversky
    Valentin I. Borshchevskiy
    Mikhail F. Yanyushin
    Ilya V. Manukhov
    Andrey V. Rogachev
    Anastasiia D. Vlasova
    Nikolay S. Ilyinsky
    Alexandr I. Kuklin
    Norbert A. Dencher
    Valentin I. Gordeliy
    Cellular and Molecular Life Sciences, 2022, 79